Amelioration of arthritis through mobilization of peptide-specific CD8 + regulatory T cells

Journal of Clinical Investigation

Volumn 123, Issue 3, 2013, Pages 1382-1389

  Leavenworth, Jianmei W ^a   Tang, Xiaolei ^a   Kim, Hye Jung ^a   Wang, Xiaoyang ^a,b,c   Cantor, Harvey ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHAPERONIN 60; HLA E ANTIGEN; METHOTREXATE; PERFORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMOBILIZED CELL; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN POLYMORPHISM; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; TH17 CELL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHAPERONIN 60; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNIZATION; INTERLEUKIN-15; MALE; METHOTREXATE; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; MUTATION, MISSENSE; PEPTIDE FRAGMENTS; PEPTIDES; PERFORIN; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84874622794     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI66938     Document Type: Article

References (45)

1. Asquith DL, Miller AM, McInnes IB, Liew FY. Animal models of rheumatoid arthritis. Eur J Immunol. 2009;39(8):2040-2044.
2. Cho YG, Cho ML, Min SY, Kim HY. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev. 2007;7(1):65-70.
3. Bevaart L, Vervoordeldonk MJ, Tak PP. Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? Arthritis Rheum. 2010;62(8):2192-2205.
4. Vinuesa CG, Tangye SG, Moser B, Mackay CR. Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol. 2005;5(11):853-865. (Pubitemid 41581667)
5. Kim HJ, Verbinnen B, Tang X, Lu L, Cantor H. Inhibition of follicular T helper cells by CD8+ Treg is essential for self tolerance. Nature. 2010; 467(7313):328-332.
6. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621-663.
7. Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol. 2004; 5(5):516-523. (Pubitemid 38660464)
8. Strange A, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010;42(11):985-990.
9. Evans DM, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43(8):761-767.
10. Nagarajan NA, Gonzalez F, Shastri N. Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat Immunol. 2012;13(6):579-586.
11. Fruci D, et al. Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues. J Cell Physiol. 2008;216(3):742-749.
12. Michaelsson J, Teixeira de Matos C, Achour A, Lanier LL, Karre K, Soderstrom K. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med. 2002; 196(11):1403-1414. (Pubitemid 35424935)
13. Davies A, et al. A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class Ia leader sequence peptide Qdm. J Immunol. 2003;170(10):5027-5033. (Pubitemid 36554733)
14. Lu L, Ikizawa K, Hu D, Werneck MBF, Wucherpfennig KW, Cantor H. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A pathway. Immunity. 2007;26(5):593-604. (Pubitemid 46756350)
15. Moon JJ, et al. Tracking epitope-specific T cells. Nat Protoc. 2009;4(4):565-581.
16. Kim HJ, Wang X, Radfar S, Sproule TJ, Roopenian DC, Cantor H. CD8+ T regulatory cells express the Ly49 class I MHC receptor and are defective in autoimmune-prone B6-Yaa mice. Proc Natl Acad Sci U S A. 2011;108(5):2010-2015.
17. Kamphuis S, et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet. 2005; 366(9479):50-56. (Pubitemid 40956530)
18. Lu L, Kim HJ, Werneck MB, Cantor H. Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc Natl Acad Sci U S A. 2008;105(49):19420-19425.
19. Leavenworth JW, Wang X, Wenander CS, Spee P, Cantor H. Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc Natl Acad Sci USA. 2011;108(35):14584-14589.
20. Rubinstein MP, et al. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. Proc Natl Acad Sci U S A. 2006;103(24):9166-9171. (Pubitemid 43902550)
21. Stoklasek TA, Schluns KS, Lefrancois L. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J Immunol. 2006;177(9):6072- 6080. (Pubitemid 44628822)
22. Cronstein BN. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev. 2005;57(2):163-172. (Pubitemid 41043882)
23. Chan ES and Cronstein BN. Methotrexate - how does it really work? Nat Rev Rheumatol. 2010; 6(3):175-178.
24. Müller-Ladner U, Ospelt C, Gay S, Distler O, Pap T. Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts. Arthritis Res Ther. 2007;9:223.
25. Morgan ME, et al. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 2003;48(5):1452-1460. (Pubitemid 36554546)
26. Kelchtermans H, et al. Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res Ther. 2005;7(2):R402-R415.
27. Oh S, Rankin AL, Caton AJ. CD4+CD25+ regulatory T cells in autoimmune arthritis. Immunol Rev. 2010; 233(1):97-111.
28. Fields ML, et al. CD4+ CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. J Immunol. 2005; 175(7):4255-4264. (Pubitemid 41361959)
29. Frey O, et al. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther. 2005; 7(2):R291-R301.
30. Korn T, Oukka M, Kuchroo V, Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol. 2007;19(6):362-371. (Pubitemid 351274046)
31. Chung Y, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med. 2011;17(8):983-988.
32. Linterman MA, et al. Foxp3(+) follicular regulatory T cells control the germinal center response. Nat Med. 2011;17(8):975-982.
33. KimHJ and Cantor H. Regulation of self tolerance by Qa-1-restricted CD8+ regulatory T cells. Semin Immunol. 2011;23(6):446-452.
34. Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigeninduced immunopathology. J Immunol. 1998; 160(11):5654-5660. (Pubitemid 28267861)
35. Amlong CA, Nardelli DT, Peterson SH, Warner TF, Callister SM, Schell RF. Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol. 2006;13(2):289-296. (Pubitemid 43383801)
36. Benito-Miguel M, et al. A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells. J Immunol. 2009;183(12):8268-8279.
37. Wu X, Pan W, He Y, Hsuchou H, Kastin AJ. Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2010;223(1-2):65-72.
38. Gomez-Nicola D, Spagnolo A, Guaza C, Nieto-Sampedro M. Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice. Exp Neurol. 2010;222(2):235-242.
39. Bluestone JA. The yin and yang of interleukin-2-mediated immunotherapy. N Engl J Med. 2011; 365(22):2129-2131.
40. Koreth J, Matsuoka K, Kim HT, McDonough SM, Bindra B, Alyea EP. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;165(22):2055-2066.
41. Saadoun D, et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med. 2011;365(22):2067-2077.
42. Leavenworth JW, Schellack C, Kim HJ, Lu L, Spee P, Cantor H. Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2. Proc Natl Acad Sci U S A. 2010;107(6):2562-2567.
43. Wu Y, Zheng Z, Jiang Y, Chess L, Jiang H. The specificity of T cell regulation that enables self-nonself discrimination in the periphery. Proc Natl Acad Sci U S A. 2009;106(2):534-539.
44. Altman JD, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274(5284):94-96. (Pubitemid 26332731)
45. Wang R, Ramaswamy S, Hu D, Cantor H. Definition of a novel binding site on CD8 cells for a conserved region of the MHC class Ib molecule Qa-1 that regulates IFN-gamma expression. Eur J Immunol. 2001;31(1):87-93.